Jassen anticancer drug ‘Dacogen Inj.’ expands insurance coverage to Leukemia
Myelodysplasticsyndrome treatment of Jassen Korea, Dacogen( ingredient : decitabine).is available to acute myelocyte leukemia which could not apply semi inducing therapy age over 65 from December 1.
But, the applied patients should be 20% or more of Bone marrow blast...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
